₹0.03
(Market cap
₹5 Cr
Recently Viewed
Clear AllMarket cap
₹5 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
325.9
P/B Ratio
0.9
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
0.1 %
ROCE
0.1 %
Industry P/E
28.73
EV/EBITDA
214.9
Debt to Equity
0
Book Value
₹0.8
EPS
₹0
Face value
1
Shares outstanding
66,069,000
CFO
₹3.02 Cr
EBITDA
₹-1.98 Cr
Net Profit
₹-1.18 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amerise Bioscience
| 21.3 | 17.5 | -11.9 | -14.0 | 0.0 | -14.8 | -- |
|
BSE Finance
| -5.3 | 9.9 | -5.4 | 2.0 | 11.6 | 11.3 | 13.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Amerise Bioscience
| -52.0 | 68.1 | -27.1 | -48.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Finance
| 15.7 | 8.7 | 17.1 | 11.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Amerise Bioscience
|
0.7 | 4.9 | 0.1 | 0.0 | -63.6 | 0.4 | 325.9 | 0.9 |
| 369.3 | 96,763.6 | 45,509.0 | 3,412.4 | 36.0 | 11.4 | 25.7 | 2.8 | |
| 1,066.7 | 30,839.4 | 1,845.0 | 975.1 | 57.4 | 25.7 | 31.6 | 7.6 | |
| 0.6 | 6.9 | 0.0 | -1.1 | -- | -10.4 | -- | 0.7 | |
| 3,618.4 | 30,041.9 | 1,148.8 | 397.2 | 38.9 | 48.6 | 75.9 | 31.3 | |
| 15.3 | 59.6 | 2.2 | 1.6 | 82.7 | 28.3 | 38.4 | 8.9 | |
| 120.1 | 11,358.4 | 10,429.1 | 657.8 | 28.4 | 12.8 | 20.8 | 2.6 | |
| 864.8 | 17,296.0 | 1,530.0 | 384.3 | 25.3 | 16.7 | 45.5 | 7.3 | |
| 719.0 | 215.7 | 112.7 | 3.2 | 3.0 | 5.5 | 66.7 | 3.7 | |
| 967.5 | 12,416.4 | 1,872.9 | 472.4 | 40.4 | 10.8 | 30.7 | 2.8 |
No Review & Analysis are available.
Amradeep Industries Limited does not have significant operations. Previously, it was engaged in the commodity trading business. The company was incorporated in 1984 and is based in Ahmedabad, India.
Incorporated
1984
Chairman
--
Managing Director
--
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Amerise Biosciences Ltd is ₹0.74 (BSE) as of 06-May-2026 IST. Amerise Biosciences Ltd has given a return of 0% in the last 3 years.
The P/E ratio of Amerise Biosciences Ltd is 325.94 times as on 06-May-2026, a 1034 premium to its peers’ median range of 28.73 times.
The P/B ratio of Amerise Biosciences Ltd is 0.91 times as on 06-May-2026, a 47 discount to its peers’ median range of 1.71 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
1,011.11
|
1.12
|
|
2024
|
0.00
|
0.81
|
|
2023
|
0.00
|
0.84
|
|
2022
|
16.37
|
1.59
|
|
2021
|
0.00
|
2.14
|
The 52-week high and low of Amerise Biosciences Ltd are Rs 0.93 and Rs 0.50 as of 06-May-2026.
Amerise Biosciences Ltd has a market capitalisation of ₹ 5 Cr as on 06-May-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Amerise Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.